In this episode, MAPS co-founder, Kirk Shepard, speaks with Niha Yerneni about joining industry through fellowship.
In episode 2 of this two-part series, a panel of experts discuss how you can structure roles and responsibilities, KPIs, and best practices to increase synergy between Medical Strategy and Medical Communications teams.
In this episode, MAPS speaks with Mark Michalski, former radiologist and currently Worldwide Head, Healthcare & Life Sciences, Artificial Intelligence and Machine Learning, Amazon Web Services about how we can catch up with big tech in our ability to mine data for meaning.
This Webinar series explores how roles and talent management have evolved, what new roles exist or are needed and what skills and competencies are required to succeed in these roles. From the manager’s perspective, we will discuss potential strategies for staying on top of this ever-changing field to manage and retain highly effective teams.
In episode 1 of this two-part series, a panel of experts in Med Comm and Med Strat will discuss the roles, best practices, & ways to measure the impact of Medical Strategy and Medical Communications.
The Medical Affairs Professional Society (MAPS) is honored to announce the appointment of Charlotte Kremer, MD, MBA as the organization’s Chief Strategy Officer in a volunteer capacity, next to her volunteer role as Chair of the Board of Directors.
The Medical Affairs Professional Society (MAPS) and the Industry Pharmacists Organization (IPhO) are pleased to announce an important new strategic collaboration to help advance the careers of student pharmacists interested in the pharmaceutical industry, as well as Fellows and early-stage Industry Pharmacist professionals.
In this episode, our expert speakers are talking about virtual scientific congresses and what has changed since the pandemic.
In this third and final podcast episode in this series, we will discuss measuring and improving the reach and engagement of scientific publications.
In this webinar, experts will lay the foundation of what conversational AI is, best and emerging practices, provide use cases, and discuss regulatory and legal considerations.